Newsletter Subject

Nurse Vaught Sentenced for Deadly Medical Error

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, May 14, 2022 11:20 AM

Email Preheader Text

Weekly Review Saturday, May 14, 2022 WORDOSIS CME SPOTLIGHT [Improving Multidisciplinary Care in Unr

[MEDPAGE TODAY]( Weekly Review Saturday, May 14, 2022 [Nurse Vaught Sentenced for Deadly Medical Error]( [Most COVID Transmission Is Still Asymptomatic]( [Large Share of Alzheimer's, Dementia Cases Tied to 8 Modifiable Risk Factors]( WORDOSIS [Play Today's Wordosis: Our Medical Word Game]( CME SPOTLIGHT [Improving Multidisciplinary Care in Unresectable Hepatocellular Carcinoma (uHCC)]( [Assessing Long COVID; Exercise to Slow Kidney Function Decline]( [How a COVID Misdiagnosis Revealed Deadly Aromatherapy Outbreak]( ADVERTISEMENT [Respiratory Therapist Charged With Murder 20 Years Later]( CME SPOTLIGHT [Shared Decision-Making as a Tool for Optimizing Management of Adverse Events]( [Do COVID Vaccines Stave Off New Medical Conditions?]( [Intensity of Thyroid Hormone Treatment Tied to Cardiovascular Mortality]( [Roe Is Under Attack: How Can I Help?]( CME SPOTLIGHT [Achieving Health Equity in Multiple Myeloma: Interprofessional Roles and Opportunities]( [Insurers Need a Reason to Care About Obesity]( [Brain Aging Markers Tied to Inflammatory Foods]( [Laughing in the Face of Death]( CME SPOTLIGHT [Advancing Clinical Decision-Making in Myelofibrosis Care: Focus on Symptom Recognition and Risk Stratification]( [Can Alternative Approaches Help in Long COVID?]( [Muscle Dysmorphia in Men: The Han Swolo Effect]( [New York Doc Tries to Take Down No Surprises Act]( CME SPOTLIGHT [Advancing Clinical Decision-Making in Myelofibrosis Care: Focus on Treatment Decision-Making]( ['I Have Never Felt Less Safe at Work']( [Sleep and Brain Health; Early Amyloid Vaccine Data; New ALS Trial Survival Analysis]( [One in Four Medicare Patients Harmed in Hospitals, Nearly Half Preventable]( CME SPOTLIGHT [Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes]( [FDA Clears TMS for OCD; Cerebral Pauses ADHD Scripts; Binge-Eating Drug Flops]( [What Penalties Will Abortion Providers Face if Roe Falls?]( [Dapagliflozin's HFpEF Win; Angiograms of the HIV+; Side Effects of PCSK9 Inhibitors?]( CME SPOTLIGHT [Overcoming Barriers to Equitable Care for Patients with Multiple Myeloma]( [55% of Hospitalized COVID Patients Still Had Symptoms at 2 Years]( [The Case of the Unknown Patient]( [Quality Group Rejects Appeal on Sepsis Measure]( CME SPOTLIGHT [Incorporating Evidence-Based Guidelines Into Personalized Treatment Decision-Making for Multiple Myeloma]( [Diabetes Screening Thresholds Should Be Lowered for Racial Minorities]( ['I've Been Verbally and Physically Assaulted': What We Heard This Week]( [Five Reasons Women in Medicine Are Burned Out]( [Gain Patients' Trust; Freebies for Healthcare Workers]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2022 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2022-05-14&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.